Sign in
4/A

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-028687

Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-04-20 Option exercise +5,000 $6.32 $31,600 6,000 D
Cohen Chad M Chief Financial Officer 2020-04-20 Option exercise +5,000 $4.07 $20,350 11,000 D
Cohen Chad M Chief Financial Officer 2020-04-20 Sale −10,000 $30.00 $300,000 1,000 D
Derivatives
Cohen Chad M Chief Financial Officer 2020-04-20 Option exercise · Stock Option (Right to Buy) −5,000 30,000 D
Cohen Chad M Chief Financial Officer 2020-04-20 Option exercise · Stock Option (Right to Buy) −5,000 740,000 D
Open-market sales · 10,000 sh · avg $30.00 · $300,000
Loading xslF345X03/doc4a.xml…